Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Conference News EACTS 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Michael O'Riordan

October 18, 2021

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Presentation TCT 2018

Case #3: Tricuspid Valve-in-Valve

Presenter: Lee N. Benson, Eric Horlick, Zahid Amin, Makram R. Ebeid, Ioannis Iakovou, Michael J. Lim, Mark Osten, Harsimran Sachdeva Singh, Nathan W Taggart

September 22, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

Advertisement

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

April 2025 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

Top Structural Heart News of 2022

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

More Support for Single Antiplatelet Therapy After TAVI

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

TCTMD’s Top 10 Most Popular Stories for July 2020

Device Explants After TAVR Rare but Risky

Case #3: Tricuspid Valve-in-Valve

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content